Related Experiment Videos
[Gastrointestinal stromal tumors].
1UO Chirurgia 2a, Ospedale Santa Chiara, Trento.
Summary
Complete surgical removal is the primary treatment for gastrointestinal stromal tumors (GIST). Advanced GIST cases are treated with imatinib, a tyrosine kinase inhibitor, alongside surgical resection.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Medical Oncology
Context:
- Gastrointestinal stromal tumors (GIST) are rare mesenchymal neoplasms.
- GISTs most frequently occur in the stomach and small intestine.
- Complete surgical resection is the current standard of care for localized GIST.
Purpose:
- To review the treatment outcomes of GIST patients.
- To evaluate the efficacy of complete negative margin resections in GIST management.
- To assess the role of imatinib in advanced GIST cases.
Summary:
- This series includes 23 patients diagnosed with GIST between 1994 and 2004.
- All patients underwent complete negative margin resections.
- Three patients had laparoscopic surgical removal.
- Advanced GIST cases were managed with imatinib, a tyrosine kinase inhibitor.
Impact:
- Highlights the importance of complete surgical resection for GIST.
- Provides insights into the management of advanced GIST with imatinib.
- Contributes to the understanding of surgical approaches, including laparoscopy, for GIST.